Trial intelligence / Profile preview

Adipose Tissue and PRP for Vulvar Lichen Sclerosus

NCT03961126Phase 2Completed

Sponsor
Health Research Institute Hospital La Fe
Start
Sep 2017
Primary completion
Dec 2019
Modality
Hydrogel Systems, Cell Therapies
Countries
1
01

Overview

Phase 2, randomised, open-label trial of autologous platelet rich gel and autologous fat tissue in vulvar lichen sclerosus (LS) (2 arms), sponsored by Health Research Institute Hospital La Fe. Primary endpoint: Vulvar elasticity measured by the cutometer-dualmpa. Started Sep 2017; status: completed.

02

Drugs

autologous platelet rich gelautologous fat tissue
03

Conditions

vulvar lichen sclerosus (LS)

Beyond the preview

Go deeper on NCT03961126.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03961126.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call